Therefore, exploring the efficacy and safety of CDC20 inhibitors in the treatment of tumors, as well as the possibility of the combination of CDC20 inhibition with other therapeutic targets, may represent a promising avenue for future interventions in the treatment of malignant tumors. This evidence concerns the gene CDC20 and cancer.